Confidence:
The Alcon Advantage

IOL Options for Every Patient

Confidence: The Alcon Advantage

IOL Options for Every Patient

AcrySof IQ Vivity^® IOL

The first and only presbyopia-correcting IOL with wavefront-shaping technology.^1-4

A close-up shot of a car’s left passenger side headlight illuminating the dark. A vertical line divides the headlight in two, with a starburst effect on the light on the left side of the line.

AcrySof^® IQ PanOptix^® IOL

Patients can now enjoy exceptional vision at every meaningful distance.^5,6

An image of an older man and his grandson sitting on a couch smiling and looking at a tablet that appears off-screen.

AcrySof^® IQ Monofocal IOL and AcrySof^® IQ Toric IOL

The trusted IOLs that give you confidence.⁷

An image of printed research papers placed on the ground in such a way that the borders of the papers create the outline of an IOL. An iPad lies on top of the papers, displaying a title page to a study on the AcrySof IQ platform. A blue medical mask lies next to the iPad. This all appears on a grey background.

Clareon^® Monofocal IOL

Our most advanced lens design that delivers pristine visual outcomes with consistency and certainty.^8-10

A close-up image of two intraocular lenses overlaid with a blue background.

Alcon Experience Academy

For relevant training content from industry thought leaders

Visit AEA Portal

References:

1. AcrySof IQ Vivity^® Extended Vision IOL Directions for Use.

2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.

3. Alcon Data on File. TDOC-0055575. 09 Apr 2019.

4. Alcon Data on File. TDOC-0055576. 09 Apr 2019.

5. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.

6. Clareon^® PanOptix^® IOL Directions for Use.

7. Market Scope. 2020 IOL Market Report – Mid-Year Update.

8. Clareon^® IOL Directions for use.

9. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.

10. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.

Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications and warnings. Please visit ifu.alcon.com for important product information.

"Exclusive Use For Health Care Professionals"

Confidence:The Alcon Advantage

IOL Options for Every Patient